OCOG-RATIONAL: A phase II randomized trial of optimal recurrence-directed therapy (RDT) without or with androgen-deprivation therapy (ADT) in radio-recurrent oligo-metastatic castrate sensitive ...
Model of targetable PARPi reversible senescence. The combination of PARPi and a senolytic was effective in preclinical models of ovarian cancer suggesting that coupling these synthetic lethalities ...
Ovarian cancer (OC) is the fifth most common cause of cancer-related mortality worldwide and represents the leading cause of death for gynecological malignancies. Nevertheless, over the last years, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback